Table 2.
Characteristics | Control group | HIV |
---|---|---|
No. HIV-1 children | 13 | 29 |
Age (years)a | 10.6 (5.3–18) | 9.7 (5.3; 17.6) |
CDC clinical category | ||
″A | – | 8 (27.6%) |
″B | – | 8 (27.6%) |
″C or AIDS | – | 13 (44.8%) |
Current immunological category | ||
″>25% CD4+ | – | 13 (44.8%) |
″15–25% CD4+ | – | 9 (31.0%) |
″<15% CD4+ | – | 7 (24.1%) |
Lymphocyte subsetsa | ||
″% CD4+ | 40.5 (29.5; 55.4) | 23.6 (2; 46.2) |
″% CD8+ | 22.1 (13.7; 28.1) | 46.6 (32; 86) |
″CD4+/mm3 | 1183 (588; 3123) | 558 (86; 2510) |
″CD8+/mm3 | 654 (304; 1641) | 1112 (339; 4276) |
Virological characteristicsa | ||
″Log10 VL (copies/ml) | – | 3.82 (1.3; 5.80) |
VL = viral load; AIDS = Acquired immunodeficiency syndrome
Values are expressed as median. (min, max). CDC: Centers for Disease Control.